The p53-mediated cytotoxicity of photodynamic therapy of cancer: Recent advances

• Published in: Toxicology and applied pharmacology Vol. 232; no. 3; pp. 487 - 497
• Main Authors: Zawacka-Pankau, Joanna, Krachulec, Justyna, Grulkowski, Ireneusz, Bielawski, Krzysztof P., Selivanova, Galina
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.11.2008; Elsevier
• Subjects: 60 APPLIED LIFE SCIENCES; AMINOLEVULINIC ACID; APOPTOSIS; Apoptosis - drug effects; Biological and medical sciences; Humans; MDM2; MDM4; Medical sciences; Medicin och hälsovetenskap; NEOPLASMS; Neoplasms - drug therapy; Neoplasms - pathology; Nuclear Proteins - physiology; p53; Photochemotherapy; Photodynamic therapy; PORPHYRINS; PROTEINS; Proto-Oncogene Proteins - physiology; Proto-Oncogene Proteins c-mdm2 - physiology; Protoporphyrin IX; Protoporphyrins - pharmacology; SENSITIZERS; Signal Transduction; THERAPY; TOXICITY; Toxicology; Tumor Suppressor Protein p53 - chemistry; Tumor Suppressor Protein p53 - physiology; Photodynamic therapy; MDM2; MDM4; Protoporphyrin IX; Aminolevulinic acid; Apoptosis; p53; Cytotoxicity; Malignant tumor; mdm2 Gene; TP53 Gene; Treatment; Cell death; C-Onc gene; Protooncogene; Cancer; Tumor suppressor gene
• ISSN: 0041-008X; 1096-0333; 1096-0333
• DOI: 10.1016/j.taap.2008.07.012

Photodynamic therapy (PDT) is a promising modality for the treatment of both pre-malignant and malignant lesions. The mechanism of action converges mainly on the generation of reactive oxygen species which damage cancer cells directly as well as indirectly acting on tumor vasculature. The exact mechanism of PDT action is not fully understood, which is a formidable barrier to its successful clinical application. Elucidation of the mechanisms of cancer cell elimination by PDT might help in establishing highly specific, non-genotoxic anti-cancer treatment of tomorrow. One of the candidate PDT targets is the well-known tumor suppressor p53 protein recognized as the guardian of the genome. Together with its family members, p73 and p63 proteins, p53 is involved in apoptosis induction upon stress stimuli. The wild-type and mutant p53-targeting chemotherapeutics are currently extensively investigated as a promising strategy for highly specific anti-cancer therapy. In photodynamic therapy porphyrinogenic sensitizers are the most widely used compounds due to their potent biophysical and biochemical properties. Recent data suggest that the p53 tumor suppressor protein might play a significant role in porphyrin-PDT-mediated cell death by direct interaction with the drug which leads to its accumulation and induction of p53-dependent cell death both in the dark and upon irradiation. In this review we describe the available evidence on the role of p53 in PDT.